Sponsored Research

We offer Sponsored Research services as part of our commitment to provide high-quality research and information to the investment community.

CROWDFUNDING AND EARLY-STAGE COMPANIES

Trethera Corporation

Connect with Investor Relations

Trethera Receives $1.8M NIH Crohn’s Grant

Trethera Zoom Webinar Invitation Sep 9 – PW v2Download
Trethera Awarded $2.3M NIH Prostate Cancer Grant 20250826Download
Trethera Zoom Webinar Invitation Sep 9 – PWDownload
Trethera Awarded $3M Lupus GrantDownload
Trethera Zoom Webinar Invitation August 14 – PWDownload

Trethera July 15 Zoom Webinar Replay

Trethera Zoom Webinar July 15 InvitationDownload
Trethera FDA Fast Track Designation Prostate CancerDownload
Q32025 Trethera SP5 Investment Overview_lockedDownload

Hotel Communication Network (HCN)

Please see our Sponsors page for HCN for additional information.

ALTERNATIVE INVESTMENTS

Aslan Capital Management

Please go to Entoro Offerboard for information on this offering.

Notice and Disclaimer: We offer Sponsored Research services as part of our commitment to provide high-quality research and information to the investment community. Paul M. Wendee & Associates, LLC may have received a flat fee from the company discussed in this report as part of a Sponsored Research agreement between Paul M. Wendee & Associates, LLC and the company; or may have an investment banking arrangement with the company. No part of Paul M. Wendee & Associates, LLC Research’s compensation is directly or indirectly related to the content of this assessment or to other opinions expressed in this report. Paul M. Wendee & Associates, LLC provides a suite of Sponsored Research services including, but not limited to, initial reports with ongoing coverage and updates; proprietary Paul M. Wendee & Associates, LLC earnings estimates; distribution to Paul M. Wendee & Associates, LLC’s clients; a license to enable the company to proactively use and distribute the report; and a press release announcing our initial coverage and updates. Paul M. Wendee & Associates, LLC may receive a part of its compensation in the form of stock or other securities issued by the company discussed in this report, and may have a long equity position or short sale position in the company’s stock. Paul M. Wendee & Associates, LLC may have been involved in underwriting securities for the subject company, and may receive proceeds or other financial benefit from any securities offering by the company. Paul M. Wendee & Associates, LLC; its officers, directors, and affiliates; and the author of this report may have a financial interest in, or affiliation with, the subject firm. Please see the other Disclaimers and Notices on the subject report and on the Intrinsic Value Wealth Report Newsletter website.